CAAS Capital Management’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,977
Closed -$187K 1042
2022
Q2
$187K Sell
3,977
-5,770
-59% -$334K 0.01% 701
2022
Q1
$877K Sell
9,747
-5,606
-37% -$570K 0.04% 329
2021
Q4
$1.58M Buy
+15,353
New +$2.18M 0.04% 356

Other funds holding UTRS

CAAS Capital Management's UTRS Position: Q3 2022 in Review

CAAS Capital Management sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q3 2022, closing a stake of 3,977 shares — an estimated $187K sold.

CAAS Capital Management first reported a position in UTRS in Q4 2021 and held it in 3 quarters. The position peaked at $1.58M in Q4 2021. 20 funds tracked by Wall St. Rank hold UTRS as of Q3 2022.

  • CAAS Capital Management reported no remaining Minerva Surgical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAAS Capital Management sold 3,977 Minerva Surgical, Inc. Common Stock shares in Q3 2022, an estimated $187K.
  • CAAS Capital Management first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • CAAS Capital Management's Minerva Surgical, Inc. Common Stock position peaked at $1.58M in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q3 2022.

Based on CAAS Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.